Pharmathen Global BV:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Pharmathen Global BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10794
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pharmathen Global BV (Pharmathen) is a pharmaceutical company with focus on the research and development of generics, active pharmaceutical ingredients (APIs), and finished formulations. Its vast product portfolio includes antibiotics, antimycotics, antivirals, antidiabetics and topical pain killers, besides topical antifungals, corticosteroids, and vitamins and minerals. Pharmathen provides comprehensive backward integrated services to customers, which include API systhesis to formulation, and production and supply of finished products. It also offers services which include drug safety and pharmacovigilance, third party auditing, regulatory affairs, quality management, medical writing and consulting services, intellectual property, and scientific operations. The company markets its products in Europe, North America, South Africa, Latin America, Middle East and North Africa, Asia and Australia. Pharmathen is headquartered in Amstelveen, Netherlands.

Pharmathen Global BV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pharmathen Global BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
BC Partners to Acquire Majority Stake in Pharmathen 10
Partnerships 11
Santhera Pharma Enters into Distribution Agreement with Pharmathen Pharma 11
Upsher-Smith Labs Enters into Agreement with Pharmathen 12
Pharmathen Pharma Enters into Co-Marketing Agreement with InterMune 13
Novartis Enters into Co-Marketing Agreement with Pharmathen Pharma 14
Pharmathen Enters Into Co-Promotion Agreement With Chiesi For Nebulized Inhaled Corticosteroid 15
Pharmathen Enters Into Co-Promotion Agreement With UCB For Allergy Products 16
Asset Transactions 17
Pharmathen Pharma Sells its Greek Commercial Operations 17
Pharmathen Global BV – Key Competitors 18
Pharmathen Global BV – Key Employees 19
Pharmathen Global BV – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Pharmathen Global BV, Pharmaceuticals & Healthcare, Key Facts 2
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pharmathen Global BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pharmathen Global BV, Deals By Therapy Area, 2012 to YTD 2018 8
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BC Partners to Acquire Majority Stake in Pharmathen 10
Santhera Pharma Enters into Distribution Agreement with Pharmathen Pharma 11
Upsher-Smith Labs Enters into Agreement with Pharmathen 12
Pharmathen Pharma Enters into Co-Marketing Agreement with InterMune 13
Novartis Enters into Co-Marketing Agreement with Pharmathen Pharma 14
Pharmathen Enters Into Co-Promotion Agreement With Chiesi For Nebulized Inhaled Corticosteroid 15
Pharmathen Enters Into Co-Promotion Agreement With UCB For Allergy Products 16
Pharmathen Pharma Sells its Greek Commercial Operations 17
Pharmathen Global BV, Key Competitors 18
Pharmathen Global BV, Key Employees 19
Pharmathen Global BV, Other Locations 20
Pharmathen Global BV, Subsidiaries 20

List of Figures
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pharmathen Global BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Pharmathen Global BV:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Southern Minnesota Municipal Power Agency:企業の発電所・SWOT分析2018
    Southern Minnesota Municipal Power Agency - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inform …
  • ImpediMed Ltd (IPD):企業の財務・戦略的SWOT分析
    ImpediMed Ltd (IPD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • GigaGen Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary GigaGen Inc (GigaGen) is a pre-clinical biotherapeutics company that develops antibody therapies to treat diseases of immune dysregulation. The company discovers and develops monoclonal and polyclonal antibody therapies and T cell therapies derived from immune repertoires. Its single cell se …
  • Kuwait Petroleum International Ltd:企業の戦略的SWOT分析
    Kuwait Petroleum International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • KeyCorp (KEY):電力:M&Aディール及び事業提携情報
    Summary KeyCorp (KeyCorp) is a bank holding company that offers a range of retail and commercial banking, consumer finance, commercial mortgage and special servicing, commercial leasing, investment management, and investment banking products and services through its principle subsidiary, KeyBank Nat …
  • Delfi Limited:企業の戦略・SWOT・財務情報
    Delfi Limited - Strategy, SWOT and Corporate Finance Report Summary Delfi Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Southwestern Energy Co (SWN):企業の財務・戦略的SWOT分析
    Southwestern Energy Co (SWN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Heroux-Devtek Inc.:企業の戦略・SWOT・財務情報
    Heroux-Devtek Inc. - Strategy, SWOT and Corporate Finance Report Summary Heroux-Devtek Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Citigroup Inc:企業の戦略・SWOT・財務情報
    Citigroup Inc - Strategy, SWOT and Corporate Finance Report Summary Citigroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Gastar Exploration Inc (GST):石油・ガス:M&Aディール及び事業提携情報
    Summary Gastar Exploration Inc (Gastar), formerly Gastar Exploration Ltd, is an energy company that offers exploration and development programs. The company explores, develops and produces natural gas, oil, and natural gas liquids. Its business activities include acquisition, identification, and exp …
  • Mithra Pharmaceuticals SA (MITRA):医療機器:M&Aディール及び事業提携情報
    Summary Mithra Pharmaceuticals SA (Mithra) is a developer and manufacturer of over the counter products and prescription drugs for women’s health and other applications. The company offers products such as estelle, donesta, tibelia, zoreline and myring, among others. Its products are used in the tre …
  • APR Applied Pharma Research SA-製薬・医療分野:企業M&A・提携分析
    Summary APR Applied Pharma Research SA (APR) is a healthcare company which focuses on the development and licenses of healthcare products for rare therapeutic areas. The company offers consumer health products, prescription healthcare products and therapeutic products. APR’s product pipeline portfol …
  • CITIC Telecom International Holdings Ltd (1883):企業の財務・戦略的SWOT分析
    CITIC Telecom International Holdings Ltd (1883) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • CK Infrastructure Holdings Ltd (1038):企業の財務・戦略的SWOT分析
    CK Infrastructure Holdings Ltd (1038) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Biotronik SE & Co KG:企業の戦略的SWOT分析
    Biotronik SE & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • STRATEC Biomedical AG (SBS):企業の財務・戦略的SWOT分析
    Summary STRATEC Biomedical AG (STRATEC), formerly Stratec Biomedical Systems AG is a medical equipment provider that develops and manufactures automated systems for clinical diagnostics. The company provides instrumentation, data management, molecular solutions, and others. It offers data management …
  • Lund University:製薬・医療:M&Aディール及び事業提携情報
    Summary Lund University (LNU) is an educational service provider that offers master and bachelor programmes. It offers education and research in the areas of engineering, economics and management, science, law, social sciences, medicine, humanities, theology, fine art, music and others. The universi …
  • ZyGEM NZ Ltd:医療機器:M&Aディール及び事業提携情報
    Summary ZyGEM NZ Ltd (ZyGEM), a subsidiary of MicroGEM International PLC is a drug development company that develops and technologies for life science, agricultural and horticultural industries. The company produces DNA extraction products, and enzymes used in diagnostics, molecular biology and indu …
  • Little Caesar Enterprises Inc:企業の戦略・SWOT・財務分析
    Little Caesar Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Little Caesar Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • AECOM (ACM):電力:M&Aディール及び事業提携情報
    Summary AECOM, formerly AECOM Technology Corporation, is a provider of engineering, consulting and project management services. The company primarily designs, builds, operates and finances various infrastructure assets for businesses, governments, and organizations. Its service offerings include ass …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆